MRNX
Defiance Daily Target 2X Long MRNA ETF
MRNX
Closed
$29.61
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
MRNX was created on 2026-02-03 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. MRNX seeks to deliver 2x leveraged exposure to the daily share price movement of Moderna, Inc. (NASDAQ: MRNA), net fees and expenses, through derivatives like swap agreements. MRNA develops mRNA-based vaccines and therapies, best known for its COVID-19 vaccine.
Company
Defiance
Asset class
Equity
Inception date
2026
Investment segment
Health Care
ISIN
US88636X8157
Website
Key stats
Open
$28.00
Volume
46.58K
AUM
$2.50M
Prev. close
$28.67
Expense ratio
1.31%
P/E
0.00
$27.01
Day’s Range
$32.65
$14.95
52W Range
$39.54
What’s in the fund
11
Total holdings
US DOLLARS
69.14%
MODERNA INC SWAP NOMURA-L
45.79%
MODERNA INC SWAP MAREX-L
39.89%
MODERNA INC SWAP CS-L
39.82%
MODERNA INC SWAP CF-L
32.16%
United States Treasury Bills 0%
24.75%
MODERNA INC.-SWAP-JNST-L
22.94%
MODERNA INC.-SWAP-NBCB-L
18.65%
First American Government Obligs X
7.50%
Others
-200.64%
Returns
Performance
_
Difference
_
Defiance Daily Target 2X Long MRNA ETF
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply